Results 7,341-7,360 of 20,763 for speaker:Alan Kelly

Public Accounts Committee: Business of Committee (29 Nov 2018)

Alan Kelly: This is a real issue. I speak with some knowledge, having been in the Department of Transport, Tourism and Sport. This is in the Department of Education and Skills, so they are the right people to bring in. However, there is a serious crossover with the Department of Transport, Tourism and Sport. We have to consider whether we should bring in some people from that Department purely on the...

Public Accounts Committee: Business of Committee (29 Nov 2018)

Alan Kelly: I am fully aware of that.

Public Accounts Committee: Business of Committee (29 Nov 2018)

Alan Kelly: It is huge.

Public Accounts Committee: Business of Committee (29 Nov 2018)

Alan Kelly: The assistant secretary in charge of land transport would be the appropriate person. There is a big overlap. We all have issues in regard to school transport, in particular constituency issues, and we all know the way in which it is structured. I have the bizarre scenario where some people living beside me are being told they have to go to school in Clare, although that is a side issue....

Public Accounts Committee: Business of Committee (29 Nov 2018)

Alan Kelly: We need the assistant secretary or whoever is the relevant person, perhaps the principal officer, in the Department of Transport, Tourism and Sport who manages Bus Éireann.

Health (Regulation of Termination of Pregnancy) Bill 2018: Report Stage (Resumed) (28 Nov 2018)

Alan Kelly: I will be withdrawing amendments Nos. 24 and 26, based on the clarification the Minister gave me earlier. However, I believe it is important the amendments were put down because they have brought about a clearer thought process and changes that have improved the Bill. The fact of the non-requirement for a time period makes a difference, as well as what has been explained to me in regard to...

Health (Regulation of Termination of Pregnancy) Bill 2018: Report Stage (Resumed) (28 Nov 2018)

Alan Kelly: I move amendment No. 26:In page 10, to delete lines 23 to 28 and substitute the following: “(4) The obstetrician referred to in paragraph (a)of subsection (2)shall make such arrangements as he or she shall deem to be necessary for the carrying out as soon as may be of the termination of pregnancy to which the certification referred to in subsection (3)relates.”. Based on...

Health (Regulation of Termination of Pregnancy) Bill 2018: Report Stage (Resumed) (28 Nov 2018)

Alan Kelly: I shall speak to amendment No. 20 which is very similar to amendment No. 19. Page 9 of the Bill contains the section which deals with "Risk to life or health". Section 11(1)( c ) contains the word "avert", as Deputy Clare Daly has outlined; perhaps other Deputies have, too. The use of the word "avert" is too absolute. I have spoken to the Minister about this issue before. Section 11(1)(...

Health (Regulation of Termination of Pregnancy) Bill 2018: Report Stage (Resumed) (28 Nov 2018)

Alan Kelly: I want to speak to amendment No. 32 in my name. It is very similar to amendment No. 33. The Minister should listen to the previous speakers. I agree wholeheartedly with what they have said. The three-day period was in the heads of the Bill, we have to accept that. How it got in there we can possibly debate another time. It is a barrier for all the reasons that have been stated. If we...

Health (Regulation of Termination of Pregnancy) Bill 2018: Report Stage (Resumed) (28 Nov 2018)

Alan Kelly: On amendment No. 11, I agree with the Minister about changing the review period to three years. A number of us are glad that the Minister listened on that issue. Five years was certainly the wrong timeframe. I support amendment No. 12. It is a good amendment because God knows we have issues in respect of proper data collection when it comes to healthcare. The specifications set out are...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: The witnesses are very welcome and I thank them for their contributions. The committee has written its report and several of us have argued and fought for various different organisations. I and Deputy Brassil and others have worked closely with the Alpha-1 foundation in its fight. In the last week or so, we secured a guarantee on the 19 remaining patients that were on clinical trials. I...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: Who decides?

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: My point is this is beyond a stakeholder.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: This is an area to which we might return. The issue of genetics is very interesting.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: Have we a copy of this? None of us has a copy of this.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: I do not want to hold up the meeting but I just wanted to ensure I was not the only person who has not seen it.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: It is obvious that we need an extensive national medicines policy to be driven at departmental level. It is to be hoped that will happen in the next Government. Mr. Judge stated that the Minister cannot get involved in drug reimbursement decisions. If that is so, what happened in the case of Orkambi? Did the Minister become involved contrary to the Act referred to by Mr. Judge or did he...

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: That is what happened with Orkambi.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: That is so in one case I am aware of.

Joint Oireachtas Committee on Health: Evaluating Orphan Drugs: Discussion (Resumed) (21 Nov 2018)

Alan Kelly: About what percentage?